Research programme: VLA-1 inhibitors - Array BioPharma/ICOS Corporation

Drug Profile

Research programme: VLA-1 inhibitors - Array BioPharma/ICOS Corporation

Alternative Names: A-328282.0; VLA-1 antagonists - Array/ICOS

Latest Information Update: 23 Mar 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Array BioPharma; ICOS Corporation
  • Class
  • Mechanism of Action Integrin alpha1beta1 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Inflammation

Most Recent Events

  • 23 Mar 2009 Discontinued for Inflammation in USA (unspecified route)
  • 16 Apr 2007 Early research in Inflammation in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top